Atrys Health, S.A. (BME:ATRY)

Market Cap	204.86M
Revenue (ttm)	226.24M
Net Income (ttm)	-24.59M
Shares Out	75.87M
EPS (ttm)	-0.32
PE Ratio	n/a
Forward PE	29.80
Dividend	n/a
Ex-Dividend Date	n/a

Volume	18,832
Average Volume	144,776
Open	2.700
Previous Close	2.700
Day's Range	2.660 - 2.700
52-Week Range	2.480 - 3.670
Beta	0.60
RSI	37.96
Earnings Date	Nov 14, 2025

About Atrys Health

Atrys Health, S.A., together with its subsidiaries, provides diagnostic services and medical treatments in Spain, Portugal, and Latin America. It operates through Diagnosis, Oncology, and Preventive Medicine segments. The company offers integrated diagnostics services comprising structural and molecular pathology, genetics, and nuclear medicine diagnosis; online medical imaging in the fields of radiology and cardiology; oncology treatment services, such as chemotherapy, immunotherapy, radiotherapy, and brachytherapy; second opinion and genetic ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2007
• Employees: 2,045
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: ATRY

Financial Performance

In 2024, Atrys Health's revenue was 218.10 million, an increase of 5.82% compared to the previous year's 206.10 million. Losses were -31.77 million, -30.30% less than in 2023.